首页> 美国卫生研究院文献>other >Patterns of Disease Progression in Metastatic Renal Cell Carcinoma Patients Treated With Antivascular Agents and Interferon: Impact of Therapy on Recurrence Patterns and Outcome Measures

【2h】

Patterns of Disease Progression in Metastatic Renal Cell Carcinoma Patients Treated With Antivascular Agents and Interferon: Impact of Therapy on Recurrence Patterns and Outcome Measures

机译：用抗病毒剂和干扰素治疗转移性肾细胞癌患者疾病进展模式：治疗对复发模式和结果措施的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe standard of care for patients with advanced renal cell carcinoma (RCC) has changed to favor targeted therapy over immunotherapy. Differences in patterns of progression between patients treated with these 2 modalities, and the impact of disease stabilization on outcome, were investigated.

著录项

期刊名称 other
作者
Elizabeth R. Plimack; Nizar Tannir; E Lin; B. Nebiyou Bekele; Eric Jonasch;
展开▼
作者单位

展开▼
年(卷),期 -1(115),9
年度 -1
页码 1859–1866
总页数 14
原文格式 PDF
正文语种
中图分类
关键词
renal cell carcinoma immunotherapy survival metastases response criteria sorafenib bevacizumab erlotinib interferon;

机译：肾细胞癌;免疫疗法;生存;转移;反应标准;索拉非尼;贝伐单抗;厄洛替尼;干扰素;

相似文献

外文文献
中文文献
专利

1. Patterns of disease progression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon: impact of therapy on recurrence patterns and outcome measures. [J] . Plimack ER, Tannir N, Lin E, Cancer: A Journal of the American Cancer Society . 2009,第9期

机译：用抗血管药物和干扰素治疗的转移性肾细胞癌患者的疾病进展模式：治疗对复发模式和结果指标的影响。
2. REAL LIFE PROGRESSION FREE SURVIVAL AND TREATMENT PATTERNS FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH TARGETED THERAPIES IN FRANCE: ANALYSIS OF IMS RWD ONCOLOGY CROSS-SECTIONAL SURVEY DATA [J] . Maroun R., Mitrofan L., Benjamin L., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：在法国针对靶向治疗的转移性肾细胞癌患者的无生命生存和治疗模式：IMS RWD肿瘤横断面调查数据分析
3. Treatment patterns and health outcomes in metastatic renal cell carcinoma patients treated with targeted systemic therapies in the UK [J] . Robert Hawkins, Kate Fife, Michael Hurst, BMC Cancer . 2020,第1期

机译：在英国有针对性系统疗法治疗的转移性肾细胞癌患者的治疗模式和健康结果
4. When to Treat Metastatic Renal Cell Carcinoma Comorbidities, Systemic Therapy, and Active Surveillance in Metastatic Kidney Cancer [C] . Brian I. Rini Genitourinary Cancers Symposium . 2012

机译：何时治疗转移性肾细胞癌的组合，全身治疗，以及在转移性肾癌中的活跃监测
5. Utilization patterns and economic impact of IV iron and erythropoiesis stimulating agents in chronic kidney disease patients: A multi-hospital study [D] . Joshi, Avani D. 2010

机译：慢性肾脏病患者静脉输注铁和促红细胞生成素刺激剂的使用模式和经济影响：一项多院研究
6. Patterns predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab [O] . Haris Zahoor, Pedro C. Barata, Xuefei Jia, 2018

机译：尼古鲁单抗治疗的转移性肾细胞癌患者的疾病进展模式预测因素和后续结果
7. Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab [O] . Haris Zahoor, Pedro C. Barata, Xuefei Jia, 2018

机译：用Nivolumab治疗的转移性肾细胞癌患者疾病进展的模式，预测因子和随后的结果

Patterns of Disease Progression in Metastatic Renal Cell Carcinoma Patients Treated With Antivascular Agents and Interferon: Impact of Therapy on Recurrence Patterns and Outcome Measures

摘要

著录项

相似文献

相关主题

期刊订阅